Table 2. Concordance between OraQuick® Ebola Rapid Antigen Test and PCR testing for living patients and the deceased from October 2015 to April 2016 in Guinea.
| Living (blood) | |||||
| PCR | |||||
| Positive | Negative | Not Tested | Total | ||
| RDT | Reactive | 5 | 8 | 0 | 13 |
| Non-reactive | 2 | 22* | 4117 | 4141 | |
| Total | 7 | 30 | 4117 | 4154 | |
| Dead (swab) | |||||
| PCR | |||||
| Positive | Negative | Not Tested | Total | ||
| RDT | Reactive | 1 | 5 | 0 | 6 |
| Non-reactive | 0 | 3093 | 52 | 3145 | |
| Total | 1 | 3098 | 52 | 3151 | |
* The algorithm for RDT use in living patients did not call for a PCR test to be done for non-reactive RDTs, PCR testing was only required for reactive RDTs, except during the March 2016 outbreak when a PCR test was required for each EVD RDT on a living patient in the affected region.